BIOMAT Database Logo BIOMAT Database Logo

[Comparative clinical study of CS-807 and cefaclor in chronic respiratory tract infections by a double-blind method]. 1988

K Shiba, and A Saito, and J Shimada, and T Miyahara, and S Onodera, and N Sasaki, and A Saito, and M Tomizawa, and I Nakayama, and M Tamura

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012141 Respiratory Tract Infections Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases. Respiratory System Infections,Upper Respiratory Tract Infection,Upper Respiratory Tract Infections,Infections, Respiratory,Infections, Respiratory Tract,Infections, Upper Respiratory,Infections, Upper Respiratory Tract,Respiratory Infections,Upper Respiratory Infections,Infection, Respiratory System,Infection, Respiratory Tract,Respiratory Infection, Upper,Respiratory System Infection,Respiratory Tract Infection
D002433 Cefaclor Semisynthetic, broad-spectrum antibiotic derivative of CEPHALEXIN. 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((aminophenylacetyl)amino)-3-chloro-8-oxo-, (6R-(6alpha,7beta(R*)))-,Ceclor,Cefaclor Anhydrous,Cefaclor Monohydrate,Keclor,Lilly 99638,S-6472,S 6472,S6472
D002506 Cephalexin A semisynthetic cephalosporin antibiotic with antimicrobial activity similar to that of CEPHALORIDINE or CEPHALOTHIN, but somewhat less potent. It is effective against both gram-positive and gram-negative organisms. 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((aminophenylacetyl)amino)-3-methyl-8-oxo-, (6R-(6alpha,7beta(R*)))-,Cefalexin,Cephalexin Dihydride,Cephalexin Hemihydrate,Cephalexin Hydrochloride,Cephalexin Monohydrate,Cephalexin Monohydrochloride,Cephalexin Monohydrochloride, Monohydrate,Cephalexin, (6R-(6alpha,7alpha(R*)))-Isomer,Cephalexin, (6R-(6alpha,7beta(S*)))-Isomer,Cephalexin, (6R-(6alpha,7beta))-Isomer,Cephalexin, Monosodium Salt,Cephalexin, Monosodium Salt, (6R-(6alpha,7beta))-Isomer,Ceporexine,Palitrex
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females

Related Publications

K Shiba, and A Saito, and J Shimada, and T Miyahara, and S Onodera, and N Sasaki, and A Saito, and M Tomizawa, and I Nakayama, and M Tamura
[Comparative clinical study of T-2588 and cefaclor in chronic respiratory tract infections by a double-blind method].
September 1986, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
K Shiba, and A Saito, and J Shimada, and T Miyahara, and S Onodera, and N Sasaki, and A Saito, and M Tomizawa, and I Nakayama, and M Tamura
[Comparative clinical study of enoxacin (AT-2266, ENX) and cefaclor (CCL) in chronic respiratory tract infections by a double-blind method].
October 1984, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
K Shiba, and A Saito, and J Shimada, and T Miyahara, and S Onodera, and N Sasaki, and A Saito, and M Tomizawa, and I Nakayama, and M Tamura
Comparative clinical study of cefcapene pivoxil and cefteram pivoxil in chronic respiratory tract infections by a double-blind method.
January 2004, The Journal of international medical research,
K Shiba, and A Saito, and J Shimada, and T Miyahara, and S Onodera, and N Sasaki, and A Saito, and M Tomizawa, and I Nakayama, and M Tamura
[Comparative clinical study of ceftazidime and cefotiam for respiratory tract infections by a double-blind method].
July 1984, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
K Shiba, and A Saito, and J Shimada, and T Miyahara, and S Onodera, and N Sasaki, and A Saito, and M Tomizawa, and I Nakayama, and M Tamura
[Comparative study of cefuzonam (CZON) with cefmenoxime in chronic respiratory tract infections by the double-blind method].
August 1986, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
K Shiba, and A Saito, and J Shimada, and T Miyahara, and S Onodera, and N Sasaki, and A Saito, and M Tomizawa, and I Nakayama, and M Tamura
[Comparative clinical study of DL-8280 and cefaclor for suppurative skin and soft tissue infections by a double-blind method].
September 1984, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
K Shiba, and A Saito, and J Shimada, and T Miyahara, and S Onodera, and N Sasaki, and A Saito, and M Tomizawa, and I Nakayama, and M Tamura
[A clinical evaluation of CS-807 in patients with urinary tract infections].
August 1988, Hinyokika kiyo. Acta urologica Japonica,
K Shiba, and A Saito, and J Shimada, and T Miyahara, and S Onodera, and N Sasaki, and A Saito, and M Tomizawa, and I Nakayama, and M Tamura
[Comparative clinical study of cefpiramide (SM-1652) and cefmetazole for the treatment of respiratory tract infections by a double-blind method].
July 1983, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
K Shiba, and A Saito, and J Shimada, and T Miyahara, and S Onodera, and N Sasaki, and A Saito, and M Tomizawa, and I Nakayama, and M Tamura
A double-blind study comparing cefaclor and amoxycillin in the treatment of respiratory tract infections in general practice.
January 1980, Pharmatherapeutica,
K Shiba, and A Saito, and J Shimada, and T Miyahara, and S Onodera, and N Sasaki, and A Saito, and M Tomizawa, and I Nakayama, and M Tamura
[A double-blind comparative study of S 6472 (a long-acting cefaclor) versus a conventional cefaclor preparation in complicated urinary tract infections].
November 1990, The Japanese journal of antibiotics,
Copied contents to your clipboard!